Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bohwa Han

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2022
Nanomaterials to improve cancer immunotherapy based on ex vivo engineered T cells and NK cellsBohwa Han, Yeonju Song, Jeehun Park, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 7, 2025
Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene DeliveryHyelee Kim, Mujin Lee, Bohwa Han, et al.
Cancer Immunology Research|March 11, 2025
Cytotoxic Chemotherapy in a 3D Microfluidic Device Induces Dendritic Cell Recruitment and Trogocytosis of Cancer CellsDohyun Park, Inae Park, Bohwa Han, et al.
Blood|December 9, 2024
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosisSeung Kwon Koh, Hyojin Kim, Bohwa Han, et al.
Experimental Hematology & Oncology|September 30, 2025
Tumor-priming CD8<sup>+</sup> natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myelomaJuheon Lee, Eunjeong Choi, Bohwa Han, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2022
Nanomaterials to improve cancer immunotherapy based on ex vivo engineered T cells and NK cellsBohwa Han, Yeonju Song, Jeehun Park, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 7, 2025
Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene DeliveryHyelee Kim, Mujin Lee, Bohwa Han, et al.
Cancer Immunology Research|March 11, 2025
Cytotoxic Chemotherapy in a 3D Microfluidic Device Induces Dendritic Cell Recruitment and Trogocytosis of Cancer CellsDohyun Park, Inae Park, Bohwa Han, et al.
Blood|December 9, 2024
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosisSeung Kwon Koh, Hyojin Kim, Bohwa Han, et al.
Experimental Hematology & Oncology|September 30, 2025
Tumor-priming CD8<sup>+</sup> natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myelomaJuheon Lee, Eunjeong Choi, Bohwa Han, et al.
Pageof 1